6 FDA warnings on file. View details
Microbial contamination with Escherichia coli O7:K1 and E. Coli 1303.
Firm ordered by consent decree to recall all products because the products were prepared, packed, or held in violation of current good manufacturing practice regulation (cGMP).
The Vitamin B17 containing product is considered to be a prescription drug, new drug, and unapproved new drug.
The product was produced using bulk L-Citrulline lot # 121109 which was subsequently recalled by the supplier since the lot was found to contain a compound other than L-Citrulline.
The product was produced using bulk L-Citrulline lot # 121109 which was subsequently recalled by the supplier since the lot was found to contain a compound other than L-Citrulline.
The dietary supplement lot contains Chloramphenicol at a level of 9.7 ppb.
All scores are algorithmically generated from publicly available label data (NIH Dietary Supplement Label Database) and reflect label quality — dosage transparency, ingredient disclosure, and formula cleanliness — not clinical efficacy, safety, or product quality. This page is not affiliated with or endorsed by Nature's Benefits. If you represent this brand and believe any information is inaccurate, please contact us for a correction. Read full methodology